权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Inflammation and delayed cognitive dysfunction after stroke

中风后炎症和迟发性认知功能障碍

基本信息

批准号：
10621096
负责人：
Kristian Paul Doyle
金额：
$ 201.69万
依托单位：
UNIVERSITY OF ARIZONA
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-03-15 至 2026-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10621096
关键词：
Ablation Adult Animal Model Anti-Inflammatory Agents Antibodies Area Atherosclerosis Automobile Driving Biochemistry Blood Vessels Bone Marrow Brain Brain region CD36 gene Cell membrane Cell physiology Cells Cerebrovascular Disorders Cholesterol Chronic Cicatrix Cognition Data Dementia Dose Encephalomalacia Enzymes Excision FDA approved Female Foam Cells Foundations Goals Heart Hematogenous Hippocampus Human Immune Impaired cognition Individual Infarction Infiltration Inflammasome Inflammation Inflammatory Inflammatory Response Injury Ischemia Knowledge Lipids Liver X Receptor Macrophage Mediating Microglia Modeling Molecular Mouse Strains Mus Myelin Myelogenous Myeloid Cells Myocardial Infarction Nerve Degeneration Outcome Pathway interactions Persons Phagocytes Plasma Process Production Publishing Quality of life Recommendation Recovery Research Role Signal Transduction Stroke Survivors Testing Therapeutic Therapeutic Effect Time Tissues Transplantation Up-Regulation aged behavior measurement brain tissue chronic stroke cognitive function cytokine experience healing hydroxypropyl-beta-cyclodextrin improved lipid metabolism lipidomics male mouse model neurotoxic novel oxidized low density lipoprotein post stroke post stroke cognitive impairment post stroke dementia prevent protein expression sensor sex single-cell RNA sequencing solute stroke model stroke recovery transcriptional reprogramming vascular cognitive impairment and dementia

项目摘要

PROJECT SUMMARY Decades of research have shown a strong association between cerebrovascular disease, including stroke, and subsequent cognitive impairment and dementia. However, vascular contributions to cognitive impairment and dementia (VCID) are still unclear. We have shown that there is a chronic inflammatory response following stroke that intensifies post-stroke injury, and in animal models, causes delayed cognitive impairment. As such, the chronic inflammatory response to stroke is a potential VCID. We recently demonstrated that at the molecular level, the chronic inflammatory response to stroke strongly resembles that seen in atherosclerosis due to the presence of foam cells, cholesterol crystals, and very similar expression of specific cytokines and degradative enzymes. In that regard, it is known that overwhelmed lipid processing within myeloid cells is a driver of atherosclerosis, features of which are dysregulated lipid metabolism within macrophages and production of high concentrations of neurotoxic cytokines and degradative enzymes. Lipids are principal structural components of myelin and are therefore major constituents of the human brain. Consequently, our overarching hypothesis is that following stroke, infiltrating macrophages and resident microglia become overwhelmed by the sheer volume of cholesterol and other lipids derived from the breakdown of myelin and other cell membranes and, as a result, cause the chronic inflammatory response described above. We propose that the permeation of cytokines and degradative enzymes produced within the infarct into neighboring brain regions is the principal cause of the encephalomalacia, or “softening,” that occurs to the tissue that surrounds chronic stroke infarcts. Thus, treatments that help phagocytic cells process the large amounts of lipid debris generated by the breakdown of brain tissue may temper the chronic inflammatory response to stroke and protect the surrounding brain tissue, thereby promoting healthier healing of the brain and improving recovery. In cases where the infarct is located within or adjacent to a brain region important for cognition, such treatments may even prevent dementia. Therefore, the goals of this proposal are to identify the pro-inflammatory lipid species generated, and pathways triggered, by the break-down of the lipid component of the brain following stroke (Aim 1); define the individual roles of pro-inflammatory lipid sensors in driving the chronic inflammatory response to stroke (Aim 2); and optimize our lipid removal approach within the area of chronic inflammation to improve recovery and prevent delayed cognitive impairment (Aim 3).

项目总结